Total planned funding: $625,099,188
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $115,088,346 |
| South Africa | $85,367,950 |
| Tanzania | $67,005,088 |
| Kenya | $63,251,631 |
| Zambia | $43,596,596 |
| Nigeria | $41,366,474 |
| Malawi | $37,597,386 |
| Uganda | $25,020,915 |
| Botswana | $24,840,039 |
| Ethiopia | $18,543,698 |
| Côte d'Ivoire | $17,187,297 |
| Rwanda | $16,815,657 |
| Namibia | $16,101,084 |
| Eswatini | $12,067,591 |
| Democratic Republic of the Congo | $10,154,812 |
| Haiti | $8,239,500 |
| Lesotho | $7,927,418 |
| South Sudan | $4,747,655 |
| Vietnam | $2,818,583 |
| Guyana | $2,800,000 |
| Ukraine | $2,450,000 |
| Zimbabwe | $1,361,468 |
| Burundi | $600,000 |
| Ghana | $150,000 |
| Cameroon | $0 |
Organizational Types
| University | $625,099,188 |
Program Areas
| Treatment | $163,409,776 |
| Prevention | $152,921,877 |
| Care | $67,831,236 |
| Testing | $46,977,159 |
| Governance and Systems | $36,484,795 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $140,835,702 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $98,905,914 |
| HVCT: Testing: HIV Testing and Counseling | $46,977,159 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $28,963,127 |
| HBHC: Care: Adult Care and Support | $25,482,259 |
| PDTX: Treatment: Pediatric Treatment | $22,474,074 |
| HVSI: Strategic Information | $17,707,199 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,839,487 |
| HVTB: Care: TB/HIV | $14,958,312 |
| HKID: Care: Orphans and Vulnerable Children | $14,310,326 |
| OHSS: Health Systems Strengthening | $13,899,281 |
| PDCS: Care: Pediatric Care and Support | $13,080,339 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,415,169 |
| HLAB: Laboratory Infrastructure | $4,878,315 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $948,881 |
| HMBL: Biomedical Prevention: Blood Safety | $488,049 |
| HMIN: Biomedical Prevention: Injection Safety | $361,250 |
| HTXD: Treatment: ARV Drugs | $100,000 |
Top Partner Programs
Johns Hopkins University:
$200,425,514
View countries